Aleor Dermaceuticals receives US FDA final approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% Read more
Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy Read more